Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Feds Confront AI Skills Gap Amid Rapid Adoption Push
As AI use cases double across government, officials said workforce understanding and trust remain key barriers to implementation.
2m read -
How Government is Using AI as a Workforce Assistant
Agencies are increasingly deploying AI assistants to support criminal investigations, software development and cybersecurity monitoring.
3m read -
GSA to Extend OneGov Software Deals in Next Phases
The future of OneGov will focus on extending discounted software agreements and expanding AI access across federal agencies.
2m read -
Agencies Shift From Fragmented IT Systems to Unified Platforms
Federal technology leaders discussed consolidating legacy tools, streamlining compliance and scaling AI to improve government efficiency.
3m read
